Determination of tobramycin in serum using liquid chromatography-tandem mass spectrometry and comparison with a fluorescence polarisation assay

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 794, Issue 2, 2003, Pages 329-335

  Keevil, Brian G ^a   Lockhart, Stephen J ^a   Cooper, Donald P ^b  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Tobramycin

Indexed keywords

ACETONITRILE; BIOASSAY; FLUORESCENCE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHANOL; PRECIPITATION (CHEMICAL); PROTEINS;

IMMUNOASSAY;

BIOMEDICAL ENGINEERING;

ANTIBIOTIC AGENT; SISOMICIN; TOBRAMYCIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; DEVICE; DRUG BLOOD LEVEL; ELUTION; FLUORESCENCE POLARIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

EID: 0041328031     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(03)00492-6     Document Type: Article

References (16)

1. Neu H.C., Dendush C.L. Ototoxicity of tobramycin; a clinical review. J. Infect. Dis. 134:1976;S206.
2. Plaut N.E., Schentag J.J., Jusko W.J. Aminoglycoside nephrotoxicity: comparative assessment in critically ill. J. Med. 10:1979;257.
3. Smith C.R., Lipsky J.J., Laskin O.L., Hellman D.B., et al. Double blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. New Eng. J. Med. 302:1980;1106.
4. Moore R.D., Smith C.R., Lipsky J.J., Mellits E.D., Lietman P.S. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann. Intern. Med. 100:1984;352.
5. Noone P., Beale D.F., Pollock S.S., et al. Monitoring aminoglycoside use in patients with severely impaired renal function. Br. Med. J. 2:1978;4670.
6. Maitra S.K., Yoshikawa T.T., Guze L.B., et al. Determination of aminoglycoside antibiotics in biological fluids. Clin. Chem. 25:1979;1361.
7. Soltes L. Aminoglycoside antibiotics, two decades of their HPLC bioanalysis. Biomed. Chromatogr. 13:1999;3.
8. UKNEQAS for Antibiotic Assays. Department of Microbiology, Southmead Hospital, Bristol.
9. Lai F., Sheehan T. Enhancement of detector sensitivity and cleanup selectivity for tobramycin through precolumn derivatization. J. Chromatogr. 18:1992;173.
10. Statler J.A. Determination of tobramycin using high-performance liquid chromatography with pulsed amperometric detection. J. Chromatogr. 27:1990;244.
11. Feng C.H., Lin S.J., Wu H.L., Chen S.H. Trace analysis of tobramycin in human plasma by derivatisation and high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B. 780:2002;349.
12. Isoheranen N., Soback S. Determination of gentamicins C1, C1a and C2 in plasma and urine by HPLC. Clin. Chem. 46:2000;837.
13. Ezan E., Emmanuel A., Valente D., Grognet J.-M. Effect of variability of plasma interferences on the accuracy of drug immunoassays. Ther. Drug Monit. 19:1997;212.
14. Heller D.N., Clark S.B., Righter H.F. Confirmation of gentamicin and neomycin in milk by weak cation-exchange extraction and electrospray ionization/ion trap tandem mass spectrometry. J. Mass. Spectrom. 35:2000;39.
15. Cherlet M., De Baere S., De Backer P. Determination of gentamicin in swine and calf tissues by high-performance liquid chromatography combined with electrospray ionization mass spectrometry. J. Mass. Spectrom. 35:2000;1342.
16. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1:1986;307.